Activated RARα counteracts the effects of TACC1v25 on the differentiation and invasion of head and neck squamous cell carcinoma.

Transl Cancer Res · 2025 · PMC12776186 · PMID 41510076

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

After ATRA treatment, the coprecipitation products of TACC1v25 and RARα exhibited a decreasing trend in the Cal27-v25 cells.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.